Citi is out with its report on AMN Healthcare Services AHS, raising its price target from $7 to $9.
In a note to clients, Citi writes, "Excluding a $1.2m bad debt charge and $2m of acquisition integration costs, normalized EBITDA of $10.4m beat our $9.2m est. D&A and interest expense were both slightly higher than our merger-model estimates. Break-even EPS beat our 4c loss estimate on lower GAAP taxes. On a segment basis, nurse/allied and HHA revs were slightly ahead, locums and permanent
placement revs were slightly below. Target price to $9 (from $7)."
Citi maintains Hold on AHS.
Shares of AHS closed Tuesday at $7.24.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.